Shanghai Changzheng Hospital: Diabetes Mellitus trials
The registry lists 11 Diabetes Mellitus studies with Shanghai Changzheng Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.
Phase 2 1Phase 3 1No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Cardiovascular-Kidney-Metabolic Syndrome in Shanghai ZicitizensRecruitingNCT07043166
- 5-MTHF Supplementation for Treatment of Type 1 Diabetes PatientsNot yet recruitingNCT06930144Not applicable
- Efficacy and Safety of LC-Z300-01 in Chinese With Type 2 DiabetesNot yet recruitingNCT06847178Phase 2/3
- UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of DiabetesRecruitingNCT06751199Not applicable
- Pancreatic Cancer and Diabetes MellitusRecruitingNCT06585072
- UCMSCs Combined With Standard Therapy for the Treatment of Newly Diagnosed Type 1 DiabetesRecruitingNCT06407297Not applicable
- Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes MellitusRecruitingNCT06196996Not applicable
- Endocrine and Exocrine Secretory Function Alterations After Moderately Severe and Severe Acute PancreatitisActive, not recruitingNCT06590935
- Hyperglycemia and Acute PancreatitisCompletedNCT06590233
- Pancreatic Surgery and Risk FactorsCompletedNCT06585046
- Autologous Regenerative Islet Transplantation for Insulin-dependent DiabetesStatus unknownNCT05294822Not applicable